Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Contract Development and Manufacturing Organisation (CDMO) Market: By Service: CMO, CRO; By CMO: API Manufacturing, Finished Product Manufacturing, Packaging; By CRO: Discovery, Preclinical, Clinical, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments

Global Contract Development and Manufacturing Organisation (CDMO) Market Outlook

The global contract development and manufacturing organisation market attained a value of about USD 177.1 billion in 2020. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 8.4% to reach nearly USD 302 billion by 2026.

 

Global Contract Development and Manufacturing Organization (CDMO) Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America and Asia Pacific to Dominate the CDMO Market

The North American region is one of the leading market regions for contract development and manufacturing organisation. This is because of the active CDMO major players in the region who are having increasing collaborations and offer diverse service features. Asia Pacific is expected to register rapid growth rate for CDMO because of the huge workforce with high skills and the lower cost advantage in the research and development and manufacturing. The government regulations and increasing emphasis on off-patent drugs have also favoured the CDMO industry in this region.

 

Contract Development and Manufacturing Organisation (CDMO): Market Segmentation

CDMO refers to the organisation which is involved in serving other pharmaceutical companies in order to provide various services such as drug development and marketing. The CDMO partners with pharmaceutical firms on contractual basis to help these firms outsource the activities such as ones that can enhance their market size and clinical research.

 

Global Contract Development and Manufacturing Organization (CDMO) Market By Service

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of service offered, the market is segmented into:

  • CMO
  • CRO

On the grounds of CMO, the industry is divided into:

  • API Manufacturing
  • Finished Product Manufacturing
    • Solid
    • Liquid
    • Injectable
  • Packaging
  • Others

On the basis of CRO, industry is classified into:

  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Discovery
  • Preclinical
  • Laboratory Services
    • Bioanalytical Services
    • Analytical Services
  • Others

The regional markets for CDMO industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Contract Development and Manufacturing Organization (CDMO) Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

CDMO Market to be Boosted by the Increasing Demand for Pharmaceutical Products

The CDMO sector has been able to swiftly provide new and effective drugs in the market through optimizing the supply chain and enhancing the marketing capabilities of pharmaceutical companies. This is bolstering the demand for CDMO market. The rising population of the world is marked with increasing acute and chronic diseases. The disposable income of the people has grown with an increasing awareness towards healthcare. This is driving the demand for pharmaceutical products in the market which leads to rapid growth of CDMO industry. The increasing investment in research and development in drugs and manufacturing by CDMOs is accelerating the industry demand. The growth of nuclear medicines and gene therapy will further augment the demand for CDMOs.

 

Key Industry Players in the Contract Development and Manufacturing Organisation Market

The report gives a detailed analysis of the following key players in the global contract development and manufacturing organisation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds: 

  • Lonza Group Ltd 
  • Catalent, Inc. 
  • Thermo Fisher Scientific, Inc. 
  • Jubilant Pharmova Ltd 
  • Aenova Holding GmbH 
  • Boehringer Ingelheim International GmbH 
  • Pfizer Inc. 
  • CordenPharma GmbH 
  • Recipharm AB 
  • Siegfried Holding AG 
  • Curia
  • Fabbrica Italiana Sintetici S.p.A 
  • Fareva SA

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Service, CMO, CRO, Region
Breakup by Service CMO, CRO
Breakup by CMO API Manufacturing, Finished Product Manufacturing, Packaging, Others
Breakup by CRO Discovery, Preclinical, Clinical, Laboratory Services, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Lonza Group Ltd, Catalent, Inc., Thermo Fisher Scientific, Inc., Jubilant Pharmova Ltd, Aenova Holding GmbH,
Boehringer Ingelheim International GmbH, Pfizer Inc., CordenPharma GmbH, Recipharm AB,
Siegfried Holding AG, Curia, Fabbrica Italiana Sintetici S.p.A, Fareva SA
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Contract Development and Manufacturing Organisation (CDMO) Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Contract Development and Manufacturing Organisation (CDMO) Historical Market (2018-2022) 
    8.3    Global Contract Development and Manufacturing Organisation (CDMO) Market Forecast (2023-2028)
    8.4    Global Contract Development and Manufacturing Organisation (CDMO) Market by Service
        8.4.1    CMO
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    CRO
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Contract Development and Manufacturing Organisation (CDMO) Market by CMO
        8.5.1    API Manufacturing
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Finished Product Manufacturing
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Solid
                8.5.2.4.2    Liquid
                8.5.2.4.3    Injectable
        8.5.3    Packaging
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Others
    8.6    Global Contract Development and Manufacturing Organisation (CDMO) Market by CRO
        8.6.1    Discovery
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Preclinical
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Clinical
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
            8.6.3.4    Breakup by Type
                8.6.3.4.1    Phase I
                8.6.3.4.2    Phase II
                8.6.3.4.3    Phase III
                8.6.3.4.4    Phase IV
        8.6.4    Laboratory Services
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022)
            8.6.4.3    Forecast Trend (2023-2028)
            8.6.4.4    Breakup by Type
                8.6.4.4.1    Bioanalytical Services
                8.6.4.4.2    Analytical Services
        8.6.5    Others
    8.7    Global Contract Development and Manufacturing Organisation (CDMO) Market by Region
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022) 
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022) 
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022) 
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2022) 
            8.7.4.3    Forecast Trend (2023-2028)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2022) 
            8.7.5.3    Forecast Trend (2023-2028) 
9    North America Contract Development and Manufacturing Organisation (CDMO) Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Contract Development and Manufacturing Organisation (CDMO) Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Contract Development and  Manufacturing Organisation (CDMO) Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Contract Development and  Manufacturing Organisation (CDMO) Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Contract Development and Manufacturing Organisation (CDMO) Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Lonza Group Ltd
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Catalent, Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Thermo Fisher Scientific, Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Jubilant Pharmova Ltd
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Aenova Holding GmbH 
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Boehringer Ingelheim International GmbH
            16.2.6.1    Company Overview
            16.2.6.2    Product Portfolio
            16.2.6.3    Demographic Reach and Achievements
            16.2.6.4    Certifications
        16.2.7    Pfizer Inc.
            16.2.7.1    Company Overview
            16.2.7.2    Product Portfolio
            16.2.7.3    Demographic Reach and Achievements
            16.2.7.4    Certifications
        16.2.8    CordenPharma GmbH
            16.2.8.1    Company Overview
            16.2.8.2    Product Portfolio
            16.2.8.3    Demographic Reach and Achievements
            16.2.8.4    Certifications
        16.2.9    Recipharm AB
            16.2.9.1    Company Overview
            16.2.9.2    Product Portfolio
            16.2.9.3    Demographic Reach and Achievements
            16.2.9.4    Certifications
        16.2.10    Siegfried Holding AG
            16.2.10.1    Company Overview
            16.2.10.2    Product Portfolio
            16.2.10.3    Demographic Reach and Achievements
            16.2.10.4    Certifications
        16.2.11    Curia
            16.2.11.1    Company Overview
            16.2.11.2    Product Portfolio
            16.2.11.3    Demographic Reach and Achievements
            16.2.11.4    Certifications
        16.2.16    Fabbrica Italiana Sintetici S.p.A
            16.2.16.1    Company Overview
            16.2.16.2    Product Portfolio
            16.2.16.3    Demographic Reach and Achievements
            16.2.16.4    Certifications
        16.2.13    Fareva SA
            16.2.13.1    Company Overview
            16.2.13.2    Product Portfolio
            16.2.13.3    Demographic Reach and Achievements
            16.2.13.4    Certifications
17    Key Trends and Developments in the Market

List of Key Figures and Tables

1.    Global Contract Development and Manufacturing Organisation (CDMO) Market: Key Industry Highlights, 2018 and 2028
2.    Global Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Service (USD Billion), 2018-2022
3.    Global Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Service (USD Billion), 2023-2028
4.    Global Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by CMO (USD Billion), 2018-2022
5.    Global Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by CMO (USD Billion), 2023-2028
6.    Global Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by CRO (USD Billion), 2018-2022
7.    Global Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by CRO (USD Billion), 2023-2028
8.    Global Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Region (USD Billion), 2018-2022
9.    Global Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Region (USD Billion), 2023-2028
10.    North America Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Country (USD Billion), 2018-2022
11.    North America Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Country (USD Billion), 2023-2028
12.    Europe Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Country (USD Billion), 2018-2022
13.    Europe Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Country (USD Billion), 2023-2028
14.    Asia Pacific Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    Asia Pacific Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Latin America Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Latin America Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Middle East and Africa Contract Development and Manufacturing Organisation (CDMO) Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Middle East and Africa Contract Development and Manufacturing Organisation (CDMO) Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Global Contract Development and Manufacturing Organisation (CDMO) Market Structure

Key Questions Answered in the Report

In 2020, the global contract development and manufacturing organisation (CDMO) market attained a value of nearly USD 177.1 billion.

The market is projected to grow at a CAGR of 8.4% between 2021 and 2026.

The market is estimated to witness healthy growth in the forecast period of 2023-2028 to reach USD 302 billion by 2026.

The major drivers of the market include the disposable income of the people and the swift provision of new and effective drugs in the market through optimising the supply chain and enhancing the marketing capabilities of pharmaceutical companies.

The contract development and manufacturing organisation (CDMO) market is being aided by disposable income of the people.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

CMO and CRO are the leading services in the industry.

API manufacturing, finished product manufacturing, and packaging, among others are the leading CMO in the industry.

Clinical, discovery, preclinical, and laboratory services, among others are the leading CRO in the industry.

The major players in the industry are Lonza Group Ltd, Catalent, Inc., Thermo Fisher Scientific, Inc., Jubilant Pharmova Ltd, Aenova Holding GmbH, Boehringer Ingelheim International GmbH, Pfizer Inc., CordenPharma GmbH, Recipharm AB, Siegfried Holding AG, Curia, Fabbrica Italiana Sintetici S.p.A, and Fareva SA.

Analyst Review

The global contract development and manufacturing organisation (CDMO) market attained a value of USD 177.1 billion in 2020, driven by the swift provision of new and effective drugs in the market through optimizing the supply chain and enhancing the marketing capabilities of pharmaceutical companies. The market is expected to witness further growth in the forecast period of 2023-2028, growing at a CAGR of 8.4%. The market is projected to reach USD 302 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its services, the contract development and manufacturing organisation (CDMO) industry can be segmented into CMO and CRO. On the basis of CMO, the market is divided into API manufacturing, finished product manufacturing, and packaging, among others. Based on CRO, the market is divided into clinical, discovery, preclinical, and laboratory services, among others. The major regional markets for contract development and manufacturing organisation (CDMO) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Lonza Group Ltd, Catalent, Inc., Thermo Fisher Scientific, Inc., Jubilant Pharmova Ltd, Aenova Holding GmbH, Boehringer Ingelheim International GmbH, Pfizer Inc., CordenPharma GmbH, Recipharm AB, Siegfried Holding AG, Curia, Fabbrica Italiana Sintetici S.p.A, and Fareva SA among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER